Georgy Sagaradze/LinkedIn
Oct 5, 2025, 05:53
Georgy Sagaradze: A Billion-Dollar In Vitro Fertilization Opportunity?
Georgy Sagaradze, Head of Precision Oncology Division at BostonGene, shared a post on LinkedIn:
“A billion-dollar in vitro fertilization opportunity: time to focus on the male factor?
Historically, male infertility has received less attention in the global infertility challenge. Yet with in vitro fertilization (IVF) achieving success in only about 30% of cases, the paradigm is shifting toward addressing male factors as well. Key drivers include:
- Growing social acceptance of assisted reproduction
- Expanding scientific evidence on the mechanisms of male infertility
- Clinical practice moving from female-centric to both-partner focus
- Rising VC investment in male infertility startups
Today this is a ~$1B niche. But with later maternal age and declining sperm quality worldwide, the opportunities ahead may be substantial.
What’s your view?
I’m ready to contribute and collaborate — who’s in?”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 20, 2025, 10:57Clare Pin-Chia Huang: New Research Links Maternal Diabetes to Pregnancy Risks
-
Dec 20, 2025, 10:53Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
-
Dec 20, 2025, 10:36Enhancing Care for Women Facing Recurrent Pregnancy Loss – SOGC
-
Dec 20, 2025, 05:00Ilana Ferhadian: Celebrating Book Launch
-
Dec 19, 2025, 16:21Launch of National Fertility Plan Marks Public Health Milestone – Collectif BAMP Association
-
Dec 18, 2025, 13:55Insights from Cendrine Siraudin on Fertility Support – Destination Santé
-
Dec 18, 2025, 13:34Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study
-
Dec 18, 2025, 13:28New Webinar on Managing Bipolar Disorder in Perinatal Patients – The Periscope Project Perinatal Specialty Consult Psychiatry
-
Dec 18, 2025, 13:16New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR